Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GENTEX CORP Director's Dealing 2025

Feb 19, 2025

30893_dirs_2025-02-19_194b5ef3-50e2-400f-9d56-a746a66052f2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2025-02-18

Reporting Person: Nash Kevin C (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-02-18 Common Stock A 15617.00 $0.00 Acquired 58107.00 Direct
2025-02-18 Common Stock F 7456.00 $24.623 Disposed 50651.00 Direct
2025-02-18 Common Stock F 8386.00 $24.623 Disposed 42265.00 Direct

Footnotes

F1: 15,617 shares are performance based shares where the total number of shares granted were based on long term performance incentives.

F2: This transaction was executed in multiple trades at prices ranging from $24.36 to $24.78. The price reported above reflects the weighted average price.